183 related articles for article (PubMed ID: 7035498)
1. Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions.
To A; Coleman DV; Dearnaley DP; Ormerod MG; Steele K; Neville AM
J Clin Pathol; 1981 Dec; 34(12):1326-32. PubMed ID: 7035498
[TBL] [Abstract][Full Text] [Related]
2. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF
Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499
[TBL] [Abstract][Full Text] [Related]
3. Epithelial Membrane Antigen. Its use in the cytodiagnosis of malignancy in serous effusions.
To A; Dearnaley DP; Ormerod MG; Canti G; Coleman DV
Am J Clin Pathol; 1982 Aug; 78(2):214-9. PubMed ID: 6179426
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies in the cytodiagnosis of serous effusions.
al-Nafussi A; Carder PJ
Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
[TBL] [Abstract][Full Text] [Related]
5. Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions.
Bramwell ME; Ghosh AK; Smith WD; Wiseman G; Spriggs AI; Harris H
Cancer; 1985 Jul; 56(1):105-10. PubMed ID: 2408723
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.
Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY
J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
Ghosh AK; Mason DY; Spriggs AI
J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
[TBL] [Abstract][Full Text] [Related]
8. Distinction between cells in serous effusions using a panel of antibodies.
Lauritzen AF
Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):299-304. PubMed ID: 2441518
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
[TBL] [Abstract][Full Text] [Related]
10. [GC12, marker of cells of mesodermal origin. Value and application to cytodiagnosis of serous effusions].
Daste G; Gioanni J; Lauque D; Kremps M; Mazeau C; Paquis P; Schneider M
Arch Anat Cytol Pathol; 1997; 45(4):185-91. PubMed ID: 9406475
[TBL] [Abstract][Full Text] [Related]
11. The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions.
Silverman JF; Nance K; Phillips B; Norris HT
Diagn Cytopathol; 1987 Jun; 3(2):134-40. PubMed ID: 2439266
[TBL] [Abstract][Full Text] [Related]
12. Value of immunocytochemistry in the study of malignant effusions.
Mason MR; Bedrossian CW; Fahey CA
Diagn Cytopathol; 1987 Sep; 3(3):215-21. PubMed ID: 3311665
[TBL] [Abstract][Full Text] [Related]
13. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions.
Gioanni J; Caldani C; Zanghellini E; Mazeau C; Duplay H; Ferrua B; Schneider M
Acta Cytol; 1991; 35(3):315-9. PubMed ID: 2042433
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
Daste G; Serre G; Mauduyt MA; Vincent C; Caveriviere P; Soleilhavoup JP
Cytopathology; 1991; 2(1):19-28. PubMed ID: 1715202
[TBL] [Abstract][Full Text] [Related]
15. Utility of HBME-1 immunostaining in serous effusions.
Ascoli V; Carnovale-Scalzo C; Taccogna S; Nardi F
Cytopathology; 1997 Oct; 8(5):328-35. PubMed ID: 9313985
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
[TBL] [Abstract][Full Text] [Related]
17. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
18. Tumour associated antigens in diagnosis of serous effusions.
Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
[TBL] [Abstract][Full Text] [Related]
19. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.
Woods JC; Spriggs AI; Harris H; McGee JO
Lancet; 1982 Sep; 2(8297):512-4. PubMed ID: 6125677
[TBL] [Abstract][Full Text] [Related]
20. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
